CHI3L1 and Alzheimer disease: Besides changes in the classical pro-inflammatory cytokines and nitric oxide pathways, analysis of the proposed AD biomarkers CHI3L1 and TREM2 may help us to understand the mechanisms involved in neuroinflammatory changes.